FDA IND approval for TB006 is a major achievement for TrueBinding and a significant potential advancement for the treatment of Parkinson’s Disease worldwide,” said Alan K. Jacobs, M.D., FAAN, Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback